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Time was, when I ﬁrst became interested in
epilepsy, nearly 40 years ago, that its management
appeared easy: it was simple to recognise and diag-
nose and simple to treat: there were then only two
mildly poisonous anticonvulsants plus a few pretty
poisonous ones hardly ever used. The two anticon-
vulsants were often combined into one ﬁxed dose
tablet. Nobody expected very much and people
with epilepsy tended to be shunned by the medical
establishment who had far more interesting things
to do.
You diagnosed epilepsy and after perhaps an elec-
troencephalogram and possibly a skull X-ray you
treated it with an anticonvulsant (sometimes two
combined). And there you stopped. The patientmay
have got better (often due to the natural history of
the disorder–—about which very little was known–—
rather than anything you had done: but people were
too polite or too ignorant to tell you). More often
the patient’s seizures continued unabated together
with any iatrogenic damage you had instituted with
your treatment: or he might die of the epilepsy (but
nobody noticed or was too bothered): or, he might
not have epilepsy at all but some other condition
altogether. But you had done your best, everyone
agreed: you were, after all, ‘‘the local man’’.
When I once remonstrated with a famous neurol-
ogist who used that phrase, that the ‘‘local man’’–—
who had to be consulted and involved, however in-
ept, in any attempt on his patch to improve epilepsy
care–—might just be a woman I was met with such a
look of blank incredulity that I resolved, there and
then, never to use the phrase again.
So, that was epilepsy. Some of us, even 40 years
ago, were dimly aware of two other things: one
was that epilepsy was not an inanimate thing but
something that people had and that, even if we
could do little for the epilepsy, we could under-
stand and befriend the people who had it and free
them from unnecessary and harmful restrictions.
Secondly, epilepsy was clearly relative: compara-
tively rare in human beings, in some animal species
it was common and might even have survival value.
Studying epilepsy in the laboratory was important,
but so was observing it in the wild: and learning
more about the natural history of epilepsy in those
human populations without access to modern anti-
convulsants might also be valuable.
And also one gradually realised there were clini-
cians who did have an abiding interest in the condi-
tion: people like Peter Jeavons, from whom I learnt
so much, or Lennox, whose book was so inﬂuen-
tial. And, often buried in the basement of medical
schools, practically unnoticed by the world around
them, were basic researchers trying to tease out
more about the brain and more about epilepsy it-
self: mainly through animal experiments because
the human brain was still largely a mystery. Then,
something apparently wonderful happened: largely
by accident and for other unplanned reasons new
anticonvulsants appeared and surgery for epilepsy
began to develop. Epilepsy became slightly sexy:
doctors, even eminent professors, began to talk
about it (and be invited to talk about it at for-
eign conferences). The pharmacological manage-
ment of epilepsy (despite the innate conservatism
of the medical profession and its leaders) had ar-
rived. Epilepsy has never been centre stage, but it
moved slightly out of the shadows as it entered the
pharmacological era of new drug treatments.
But now, in the new millennium we realise its
limitations: there are new drugs with fewer side
effects than the old and with a greater range (but
much more expensive): but for many people with
epilepsy things haven’t changed very much. Still
about a third cannot be helped with conventional
drug therapy (although some can be actually cured
by surgery) and a third would get better without
any help from us: only about a third really beneﬁt
from the medications we give them: we are per-
haps on the threshold (although not quite there
yet) of recognising which of these three groups
people with epilepsy fall into. Some people start
epilepsy and lose it spontaneously: some lose it but
need treatment to do so: some don’t respond at all
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to treatment (no matter what) or only temporarily
and then relapse. Some endure seizures and seem
to suffer no ill effects: others have a progressive
epilepsy with increasing brain damage. Epilepsy, as
we remind our students–—or should–—is not a single
disease entity although we often seem to treat it
as though it was.
What has really changed in epilepsy in the last 40
years is our understanding of it: of its many and var-
ied causes, of its natural history, of its antecedents
and of its genetics. We are not there yet, but we
are on the threshold of understanding it better. And
what has happened in the last 40 years is that clin-
ical and preclinical workers have grown closer to-
gether and are beginning to understand each other
better: in particular are starting to agree about
what knowledge has to be gained, what experi-
ments are needed to really understand it.
This is the message from the ﬁrst book ‘‘Do
Seizures Damage the Brain’’. Not whether they do
or not (some seizures seem to in some brains, but
there is still doubt and controversy about whether
this happens, to whom and whether it matters)
but more importantly the message is that experi-
menters and clinicians are starting to ask the same
questions and looking for the same answers–—and
that those answers, with the right experiments and
studies, are obtainable. There are minor faults in
this book (one drug, part sponsoring the meeting
from which the book derives, is over represented)
but its great strength is that it passes from animal
and preclinical studies to human and clinical stud-
ies effortlessly and reveals the strengths, weak-
nesses and future of both. It is a book that should
be read by all of us with an interest in epilepsy
(even if some places a triﬂe slowly and painfully)
because it is an important book from which I have
learnt much and which has given me, even towards
the end of my career, an idea of what one of the
futures of epilepsy is likely to be.
The second book is very different. The physics
of epilepsy (even though we see epilepsy as a
physico-chemical disorder) has been little studied
and little written about. This book (‘‘Epilepsy as
a Dynamic Disease’’) does just that. Now physics
(even the physics of 40 years ago) is not my strong
point (when I managed to pass A level physics my
patient hard working physics master died within
one week of this remarkable event in history).
Since some of the pages consist of tightly packed
mathematical equations of the type I used to stare
at blankly during my adolescence progress in read-
ing the book was slow: but I am glad I didn’t skip
too much or discover the useful summary at the
end, until the end of the book.
Because I learnt much from this book: there is
a different way of looking at the brain and how it
works than just considering its chemistry. Epilepsy’s
physics may be equally important ‘‘unstable pe-
riodic orbits’’. The authors envisage eventually
devices that will deliver electrical stimuli to the
brain to abort seizures which will only ‘‘ﬁre’’ when
needed (they point out that one has to take medi-
cation continually to prevent what may be only two
seizures a year). Such devices, if built, if simple
yet powerful enough and delivering stimuli in the
right place at the right time may change the way
we regard and treat epilepsy and make drug treat-
ment redundant. They have not yet been built,
but the authors are conﬁdent they will be: if they
are right they may change the way we think about
epilepsy, particularly if we can explain why some
epilepsies get better (with or without our assis-
tance) and some do not. This book may turn out
to be completely off the point and total nonsense:
but I recommend it to you. If you have an interest
in epilepsy I hope you ﬁnd it as thought provoking
as I did.
One book, of course, remains to be written: the
brain is a physico-chemical machine: but it is also a
psychological one. Psychology, as a science, is in its
pre-infancy and the book cannot yet be written. But
one day, perhaps in a hundred years, it will be: and
the psychological treatment of seizures at present
haphazard and chance driven, eschewing both phys-
ical and chemical methods will assume its rightful
place in the therapeutic armentarium.
I commend both these books (and the, as yet,
unwritten one) to you: towards the end ofmy career
in epilepsy they persuade me that the last 40 years
have not been entirely wasted.
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